Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Vaccine Development. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN113234113A details organic catalysis for 1,2-cis-glycosidic bonds. Enhances supply chain reliability and cost efficiency for vaccine antigen manufacturing.
Novel unnatural amino acid synthesis improves MAPS polypeptide purity and yield via symmetric branching, offering cost-effective pharma intermediate solutions.